Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB25FR1JW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,881
Award facts
- Contract value 100% obligated
- $3,881.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,881.10 by the Defense Logistics Agency on September 16, 2025, for the supply of Botox 200 unit vials. The contract utilizes firm fixed-price pricing with no set-aside designation and carries an ultimate completion date of October 7, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which is valued at approximately $500 million and remains valid through November 2026.
The Defense Logistics Agency leverages this master contract vehicle to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables, to support the medical supply requirements of Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing delivery orders for specialized pharmaceutical products including injectable medications, vaccines, and specialty treatments that serve military health systems. The company's positioning as a woman-owned small business has enabled it to compete effectively in federal procurement markets while maintaining a robust portfolio of medical product deliveries to the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DB25FR1JW?
SPE2DB25FR1JW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FR1JW worth?
The government has obligated $3,881 on SPE2DB25FR1JW.
Is contract SPE2DB25FR1JW an order under another contract?
Yes. SPE2DB25FR1JW is a delivery order under SPE2DB22D9251, an indefinite delivery contract.
Was contract SPE2DB25FR1JW competed?
The extent of competition for SPE2DB25FR1JW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award